Vers la page d'accueil

Comment ça fonctionne

Nous avons repensé la recherche de clinique pour la rendre simple, rapide et personnelle.
Répondez à quelques questionsComplétez un bref formulaire pour décrire votre situation et vos besoins médicaux.
Obtenez offres personnalisées3 cliniques, sélectionnées selon vos réponses, proposent des plans de traitement et des devis personnalisés.
Choisissez la meilleure option Comparez les offres et choisissez la clinique qui vous convient le mieux.
Vous pouvez aussi consulter les 3 cliniques ci-dessous.
820К+ patients ont reçu de l'aide depuis 2014
50 pays
1,500 cliniques
6K+ avis
3K+ médecins qualifiés

Quel est le Coût du Diagnostic et du Traitement de thrombocytopénie en Autriche ?

Le prix est donné sur demande
AutricheTurquieEspagne
Traitement symptomatiquede $700de $300de $800
Plasmaphérèsede $2,000de $1,200de $1,800
Аphérèse thérapeutique-de $1,350-
Échange de plasma-de $3,900-
Données vérifiées par Bookimed en June 2026, sur la base des demandes des patients et des devis officiels de 65 cliniques dans le monde. Les coûts médians sont calculés à partir de factures réelles (2025–2026) et mis à jour chaque mois. Les prix réels peuvent varier.

Découvrez les Meilleures Cliniques pour le Traitement de thrombocytopénie en Autriche : 3 Options Vérifiées et Prix

Le classement des cliniques Bookimed est basé sur des algorithmes de science des données, offrant une comparaison fiable, transparente et objective. Il prend en compte la demande des patients, les notes d'évaluation (positives et négatives), la fréquence des mises à jour des options de traitement et des prix, la vitesse de réponse et les certifications des cliniques.
Wiener Privatklinik
Döbling Private Hospital
Vienna General Hospital (AKH)

Obtenez une évaluation médicale Thrombocytopénie en en Autriche : consultez des médecins expérimentés maintenant

Voir tous les médecins
Vérifié

Wolfgang Köstler

22 années d'expérience

Un oncologue de premier plan et professeur à l'Université de médecine de Vienne, spécialisé dans la thérapie systémique personnalisée contre le cancer. Il reçoit désormais des patients à la Wiener Privatklinik.

  • Plus de 20 ans d'expérience clinique et de recherche en oncologie médicale
  • Spécialiste du traitement du cancer du sein et des tumeurs gynécologiques
  • Expert en thérapies ciblées contre le cancer, en immunothérapie et en médecine de précision
  • Ancien chef adjoint de la division clinique d'oncologie de l'hôpital universitaire de Vienne
  • Rédiger des recherches sur le développement de biomarqueurs et la résistance aux médicaments
Vérifié

Johannes Drach

L'oncologue de premier plan, le professeur Drach, dirige depuis des années une prestigieuse clinique pour les néoplasies myéloprolifératives. Il propose à la fois une pratique privée et une direction clinique à l'hôpital privé Confraternitaet de Vienne.

  • Professeur à l'Université de médecine de Vienne
  • Plus de 15 ans à la tête d'une clinique universitaire spécialisée dans le myélome et le lymphome
  • Recherche spécialisée effectuée au M.D. Anderson Cancer Center aux États-Unis
  • Formation continue en nutrition oncologique à l'Université de Fribourg
  • Publication de plus de 120 articles scientifiques dans son domaine

Partager ce contenu

Histoires vidéo des patients de Bookimed

Dayana
J'ai combiné mes vacances à Antalya avec un bilan de santé.
Procédure: Bilan féminin
Igor
C'était génial ! Transferts, hébergement, traitement – tout était inclus.
Procédure: Implant dentaire
Clinique: WestDent Clinic
Marina
Bookimed s’est occupé de tout. Je n’avais aucun souci à me faire.
Procédure: Bilan féminin
Mis à jour: 05/27/2022
Rédigé par
Anna Leonova
Anna Leonova
Responsable de l'équipe marketing de contenu
Auteur médical certifié avec 10+ ans d'expérience, créateur des contenus fiables de Bookimed, soutenus par un Master en philologie et des interviews avec des experts médicaux internationaux.
Fahad Mawlood
Éditeur Médical et Scientifique des Données
Praticien généraliste. Lauréat de 4 prix scientifiques. Diplômé en Asie occidentale. Ancien Chef d'une équipe médicale aidant les patients arabes. Aujourd'hui responsable du traitement des données et de l'exactitude du contenu médical.
Fahad Mawlood Linkedin
Cette page peut contenir des informations relatives à diverses conditions médicales, traitements et services de santé disponibles dans différents pays. Veuillez noter que le contenu est fourni à des raisons d'information seulement et ne devrait pas être interprété comme conseil médical. Veuillez consulter votre médecin ou un professionnel de la santé qualifié avant d'entreprendre ou de changer de traitement médical.

FAQ sur le Traitement de thrombocytopénie en Autriche

Ces FAQ sont basées sur les questions de patients réels cherchant des soins médicaux avec Bookimed. Les réponses sont fournies par des experts médicaux et des représentants de cliniques réputées.

At what platelet count will an Austrian hematologist initiate treatment?

Austrian hematologists typically initiate treatment for thrombocytopenia when platelet counts fall below 20,000 to 30,000/µL. Decisions are highly individualized. Doctors prioritize clinical symptoms like bleeding or bruising over lab values alone. High-risk factors or upcoming surgeries may trigger earlier intervention at higher levels.

  • Immune thrombocytopenia threshold: Treatment usually starts below 30,000/µL for newly diagnosed patients.
  • Prophylactic transfusion level: Stable patients receive transfusions when counts drop below 10,000/µL.
  • High-risk monitoring: Intervention occurs at 20,000/µL if infections or fever are present.
  • Surgical requirements: Doctors raise platelet levels higher before invasive procedures or dental work.

Bookimed Expert Insight: Top Austrian specialists like Dr. Johannes Drach at Medical University of Vienna emphasize clinical trends over single data points. Large academic centers like Vienna General Hospital (AKH) manage over 590,000 patients annually. This high volume allows hematologists to utilize advanced immunograms to distinguish between immune-driven and bone-marrow-related causes before starting therapy.

Patient Consensus: Patients note that doctors often choose a watch and wait approach for stable counts between 70,000 and 100,000/µL. Many emphasize that visible symptoms like gum bleeding or blood blisters usually trigger treatment faster than a dropping number on a lab report.

What are the first-line treatment options in Austria?

First-line thrombocytopenia treatment in Austria focuses on hematologist consultations and immunograms for precise diagnosis. Standard protocols utilize corticosteroids, such as prednisone, or intravenous immunoglobulin (IVIG) for rapid platelet stabilization. Clinics like Wiener Privatklinik and Vienna General Hospital (AKH) provide these university-level care standards in Vienna.

  • Specialist access: Patients can consult hematologists directly without mandatory general practitioner referrals.
  • Diagnostic testing: Immunograms and specialized blood panels confirm autoimmune or systemic triggers.
  • Initial medication: Prednisone or dexamethasone pulses serve as the primary pharmacological intervention.
  • Emergency measures: IVIG or platelet transfusions provide immediate rescue for acute bleeding risks.

Bookimed Expert Insight: Patients seeking treatment in Vienna benefit from concentrated expertise within a single district. Vienna General Hospital (AKH) serves over 595,000 patients annually and shares many specialists with neighboring private facilities. This means a patient at Wiener Privatklinik often receives a care plan designed by the same university professors who lead European hematology research.

Patient Consensus: Patients note that doctors often choose watchful waiting if platelet levels remain stable without bleeding. When treatment starts, they emphasize that the goal is preventing hemorrhage rather than reaching a normal laboratory count.

What second-line therapies are available if initial treatment fails?

Second-line thrombocytopenia therapies in Austria include thrombopoietin receptor agonists (TPO-RAs), rituximab, or surgical splenectomy. Specialists pivot to these options if corticosteroids or IVIG fail. Treatment plans prioritize stabilizing platelet counts to prevent bleeding using individualized drug sequencing and modern clinical protocols.

  • Targeted medications: TPO-receptor agonists like Revolade or Nplate stimulate platelet production.
  • Immunotherapy: Rituximab targets B-cells to reduce autoimmune platelet destruction mechanisms.
  • Surgical intervention: Splenectomy involves removing the spleen to stop premature platelet clearance.
  • Bridge therapies: Urgent cases utilize platelet transfusions or high-dose steroids for stability.

Bookimed Expert Insight: Austrian hematology centers like Vienna General Hospital (AKH) manage vast patient volumes, serving over 590,000 cases annually. This high throughput allows senior specialists like Dr. Wolfgang Köstler to refine second-line protocols based on specific resistance mechanisms. Patients often find that clinics like Wiener Privatklinik offer more personalized monitoring for dose adjustments compared to larger public institutions.

Patient Consensus: Patients note that TPO-receptor agonists are the most common next step when steroids fail. Many prefer trying rituximab to avoid the infection risks associated with a splenectomy.

Will Austrian public health insurance cover advanced ITP drugs?

Austrian public health insurance covers advanced Immune Thrombocytopenia drugs like TPO receptor agonists and SYK inhibitors. Coverage requires prior authorization from a chief medical officer. Treatments are typically approved after first-line therapies like corticosteroids or immunoglobulins fail to stabilize platelet counts.

  • Approval protocol: A chief medical officer (Chefarzt) must authorize dispensing high-cost ITP medications.
  • Clinical necessity: Hematologists must document failing first-line therapies or intolerable side effects.
  • Prescription source: Medication must come from contracted public doctors or public hospital clinics.
  • Patient costs: Approved drugs cost a standard prescription fee of approximately €8 per item.

Bookimed Expert Insight: Patient volume data highlights Vienna General Hospital (AKH) as a primary hub. It serves 595,000 patients annually and houses 42 university institutes. For complex ITP cases, top specialists often hold professorships at the Medical University of Vienna. These doctors, like Dr. Wolfgang Köstler, often lead clinical trials for targeted therapies. Choosing a specialist with such academic credentials can streamline the rigorous medical documentation needed for insurance approval.

Patient Consensus: Patients note that specialist approval determines coverage success more than just having insurance. The process feels bureaucratic, often requiring detailed records of bleeding episodes and prior treatment failures to secure authorization.

Which Austrian centers specialize in complex or chronic thrombocytopenia?

Austria treats complex thrombocytopenia through major university hematology departments and accredited private centers. Top facilities include Vienna General Hospital (AKH) and Wiener Privatklinik. These centers utilize advanced diagnostics like immunograms and specialized consultation with board-certified hematologists to manage chronic platelet disorders.

  • University hospital care: AKH Vienna features 6 in-house labs for deep blood analysis.
  • Specialized expertise: Wiener Privatklinik employs over 400 physicians, including university professors.
  • Patient safety: Döbling Private Hospital implements JCI-standard safety protocols for complex cases.
  • Clinical infrastructure: Large public hospitals like AKH provide 1,600 doctors for multidisciplinary care.

Bookimed Expert Insight: While public university hospitals handle the highest volume of cases, private facilities in Vienna offer faster access to the same elite medical faculty. Many top specialists, such as Dr. Wolfgang Köstler, hold positions at both the Medical University of Vienna and private clinics. Choosing a private center often ensures more personal coordination without sacrificing the expertise found in public academic institutions.

Patient Consensus: Patients emphasize seeking large tertiary centers in Vienna for complex blood workups. They note that specialized hematology units are better at identifying subtle underlying immune or marrow issues.

Do I need a referral to see a hematologist in Austria?

You do not strictly need a referral to see a hematologist in Austria for thrombocytopenia. Private specialists at facilities like Wiener Privatklinik or Döbling Private Hospital accept direct bookings. Public insurance users often require a GP referral to ensure full coverage and prioritize appointments.

  • Private access: Book directly with specialists like Dr. Johannes Drach without a referral.
  • Insurance rules: Public coverage typically requires a referral to avoid reimbursement issues.
  • Wait times: Referrals often help secure faster appointments at high-volume centers like Vienna General Hospital.
  • Initial diagnostics: GPs usually perform necessary blood work before recommending a hematology specialist.

Bookimed Expert Insight: While private clinics like Wiener Privatklinik allow direct access to professors from the Medical University of Vienna, starting with an internist first is often more efficient. Our data shows that top specialists prioritize patients with a confirmed trend of low platelet counts over single readings. Direct bookings at premier private hospitals are common for international patients seeking second opinions from renowned experts like Dr. Wolfgang Köstler.

Patient Consensus: Patients note that private clinics offer much faster access, but suggest bringing a history of previous blood tests to the first visit. Most recommend seeing a general practitioner first to rule out simple infections before seeking an expensive specialist consultation.

What daily precautions should I take during treatment?

Daily precautions focus on preventing bleeding and managing injury risks while platelets are low. Patients should avoid aspirin and ibuprofen, as these medications further impair clotting. Use an electric razor to prevent nicks. Opt for a soft-bristle toothbrush to protect sensitive gums during hygiene routines.

  • Medication safety: Avoid NSAIDs like ibuprofen or naproxen to reduce hemorrhage risks.
  • Physical activity: Skip contact sports or heavy lifting to prevent internal bleeding.
  • Dental care: Use soft toothbrushes and avoid aggressive flossing to stop gum bleeds.
  • Injury monitoring: Track new bruises or petechiae using photos for your hematologist.

Bookimed Expert Insight: Vienna has a unique concentration of university-level expertise. Many specialists at Wiener Privatklinik and Vienna General Hospital are professors at the Medical University of Vienna. This academic connection is vital for thrombocytopenia patients. Researchers like Dr. Wolfgang Köstler or Dr. Johannes Drach treat complex cases using translational research. This ensures patients receive the most current evidence-based protocols directly from the sources of medical innovation.

Patient Consensus: Patients emphasize checking cold and flu medications as they often contain hidden aspirin. Many suggest carrying a medical alert card to ensure emergency responders know your diagnosis immediately.

Obtenez une consultation gratuite

Sélectionnez la meilleure façon de vous contacter